Biomedical subjects

Lena Jönsson

Publications and source records attributed to Lena Jönsson.

4 recordsLinked to original sources

PubMed2005

Dosimetry calculations on a tissue level by using the MCNP4c2 Monte Carlo code.

OBJECTIVE: The aim of this study was to develop a MCNP4c2-code and to further refine the small-scale anatomy intestinal dosimetry model based on a EGS4-code developed by Jonsson et al.(1,2) METHOD: The small intestine was modeled as a hexagonal tube system and includes cross-dose contribution from activity in nearby intestine loops. The model includes villi (height, 500 microm), radiosensitive crypt cells (height, 150 microm), and an overlying mucus layer of thicknesses (5-200 microm). The developed intestinal model used in either of the two Monte Carlo codes make it possible to calculate S-values and subsequent mean absorbed dose to the radiation-sensitive crypt cells in the small intestinal wall by considering contributions from the self-dose and from the cross-dose from nearby intestinal loops. Results are given for monoenergetic electrons and photons and for full decay schemes of (99m)Tc, (111)In, (131)I, (67)Ga, (90)Y, and (211)At. RESULTS: Results show that the cross-dose from nearby intestinal loops is significant, and that the fraction of cumulated activity in the intestinal wall contents is important for accurate absorbed-dose estimation. CONCLUSION: It is evident from our study that previous Medical Internal Radiation Dose (MIRD) and International Conference on Radiological Protection (ICRP) models tend to overestimate the absorbed dose to the wall. Our work on the gastrointestinal tract model includes several noticeable refinements, as compared to the MIRD- and ICRP model, and the "onion shell" geometry can easily be transferred to similar geometrical dosimetry applications.

Astatine↗

PubMed2005

Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom.

UNLABELLED: Activity determination from scintillation camera images using the conjugate view method may be inaccurate because of variation in scattered radiation from adjacent organs and activity from overlapping tissues. The aim of this study was to simulate patient scintillation camera images and from these evaluate the accuracy of 2 correction methods. The contribution from overlapping tissue activity was also calculated for some organs. METHODS: Biokinetic data for (99m)Tc-sestamibi obtained in rats was used as input to simulate scintillation camera images with a voxel-based computer phantom using the Monte Carlo method. The organ activity was calculated using the conjugate view method with either the effective attenuation coefficient method or scatter correction using the triple-energy window (TEW) method combined with attenuation correction with a transmission factor image. Images were simulated with activity in organs one by one to evaluate the accuracy of the 2 correction methods and to evaluate the activity contribution from activity in adjacent or overlapping tissues. To allow comparison with the clinical situation, the total activity distribution from the animal study was used to simulate scintillation camera images at different points in time and the calculated activity was compared with both the input data and some patient data from the literature. RESULTS: The combination of scatter and attenuation correction gave the most accurate calculated activity, +/-10% of the true activity from the images with activity in one organ at a time. In the images similar to the clinical situation, the kidney activity was overestimated up to a factor of 34, mainly because of excretion of activity through the intestines. CONCLUSION: The scatter correction using the TEW method in combination with attenuation correction with the measured transmission factor resulted in the most accurate activity determination of the methods used. This study also shows that organ activity data calculated from scintillation camera images may be overestimated by >90% because of activity in overlapping tissues.

Animals↗

PubMed2003

Crypt cell dosimetry for 99Tcm-sestamibi in a new small intestinal dosimetry model.

The aim of the study was to calculate the absorbed dose to the crypt cells in the small intestine from (99)Tc(m)-sestamibi excreted through the intestinal tract. The absorbed dose was calculated taking into consideration the biodistribution of the radiopharmaceutical in the small intestinal wall and its contents, based on data gathered in rats. Absorbed dose calculations were performed using a new intestinal model in which S values for crypt cells are given both for the intestinal wall and for the intestinal contents as source organs. A maximum of 6% of the injected activity was found to be located in the intestinal wall at 30 minutes after injection and 13% in the intestinal contents at 2 h, resulting in an absorbed dose of 8.9 microGy/MBq to the crypt cells. Assuming the activity to be located only in the wall, we calculate an absorbed dose to the crypt cells 2.5 times higher than if all the activity is assumed to be present in the intestinal contents. Using the new intestinal dosimetry model, together with detailed biokinetic data for the radiopharmaceutical from animal studies, it is possible to calculate the absorbed dose to the crypt cells, which is not possible when using external imaging.

Animals↗

PubMed2002

A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses.

UNLABELLED: Current internal radiation dosimetry models for the small intestine, and for most walled organs, lack the ability to account for the activity uptake in the intestinal wall. In existing models the cross-dose from nearby loops of the small intestine is not taken into consideration. The aim of this investigation was to develop a general model for calculating the absorbed dose to the radiation-sensitive cells in the small intestinal mucosa from radionuclides located in the small intestinal wall or contents. METHODS: A model was developed for calculation of the self-dose and cross-dose from activity in the intestinal wall or contents. The small intestine was modeled as a cylinder with 2 different wall thicknesses and with an infinite length. Calculations were performed for various mucus thicknesses. S values were calculated using the EGS4 Monte Carlo simulation package with the PRESTA algorithm and the simulation results were integrated over the depth of the radiosensitive cells. The cross-organ dose was calculated by summing the dose contributions from other intestinal segments. Calculations of S values for self-dose and cross-dose were made for monoenergetic electrons, 0.050-10 MeV, and for the radionuclides (99m)Tc, (111)In, (131)I, (67)Ga, (90)Y, and (211)At. RESULTS: The self-dose S value from activity located in the small intestinal wall is considerably greater than the S values for self-dose from the contents and the cross-dose from wall and contents except for high electron energies. For all radionuclides investigated and for electrons 0.10-0.20 MeV and 8-10 MeV in energy, the cross-dose from activity in the contents is higher than the self-dose from the contents. The mucus thickness affects the S value when the activity is located in the contents. CONCLUSION: A dosimetric model for the small intestine was developed that takes into consideration the localization of the radiopharmaceutical in the intestinal wall or in the contents. It also calculates the contribution from self-dose and cross-dose. With this model, more accurate calculations of absorbed dose to radiation-sensitive cells in the intestine are possible.

Electrons↗